Je. Jalil et al., Effects of antihypertensive treatment on cardiac IGF-1 during prevention of ventricular hypertrophy in the rat, LIFE SCI, 64(18), 1999, pp. 1603-1612
There is some evidence that cardiac rather than circulating insulin-like gr
owth factor-1 (IGF-1) levels contribute to the development of renovascular
hypertensive left ventricular hypertrophy (LVH), remaining unknown the effe
cts of antihypertensive drugs on IGF-1 levels. We have assessed here the pr
eventive effects of enalapril, losartan, propanolol and a-methyldopa on lef
t ventricle (LV) and circulating IGF-1 levels in a rat model of hypertensio
n and LVH (Goldblatt, GB). Our results show that relative LV mass and the L
V content of IGF-1 were significantly lower with all antihypertensive drugs
in GB rats (p<0.001). Serum concentrations of IGF-1 were lower in GB rats
treated with enalapril, a-methyldopa and propanolol (p<0.01), but not in th
ose treated with losartan. These results support the hypothesis that local
rather than seric IGF-I contributes to the development of left ventricular
hypertrophy induced by pressure overload in the rat.